What Does a Cellular Fibroepithelial Lesion Mean on Biopsy?

Seeing the words “cellular fibroepithelial lesion” on your breast biopsy report can be alarming. It is important to understand that this phrase is an “indeterminate” or inconclusive result, rather than a final diagnosis ^[1][2].

It means the pathologist sees a growth made of the two types of tissue typically found in a fibroadenoma (glandular and connective/stromal tissue), but the connective tissue has more cells than usual ^[3][1]. Because of this increased “cellularity,” the pathologist cannot definitively tell whether the lump is a common fibroadenoma or a less common growth called a phyllodes tumor ^[1][4]. While a cellular fibroepithelial lesion is not a diagnosis of ordinary breast cancer, a needle biopsy alone cannot reliably rule out a phyllodes tumor, which can be benign, borderline, or malignant ^[1][2][4].

Why is the Diagnosis Inconclusive?

A core needle biopsy only removes tiny pieces of a lump ^[5]. While this is usually enough to diagnose most breast conditions, fibroepithelial lesions can be tricky. A phyllodes tumor and a cellular fibroadenoma can look nearly identical under a microscope ^[3]. To confidently tell them apart, a pathologist looks for specific structural features—like the way the tumor borders interact with surrounding tissue, or specific leaf-like growth patterns ^[6][7].

Because a needle biopsy only captures a small fraction of the lump, it might miss the specific areas that contain these defining clues ^[5][8]. The pathologist uses the umbrella term “cellular fibroepithelial lesion” to say that they need to examine the whole lump to know exactly which type it is ^[2][9].

Understanding the Medical Terms

Your pathology report might mention some of these specific terms:

• Biphasic: Made of two tissue types (glandular and stromal). Both fibroadenomas and phyllodes tumors are biphasic ^[1].
• Stromal overgrowth: An area where the connective (stromal) tissue has overgrown the glandular tissue, which is a feature more common in phyllodes tumors ^[6].
• Mitoses: A measure of how quickly the cells are dividing ^[6].
• Imaging-pathology concordance: Whether your biopsy results adequately explain what the radiologist saw on your ultrasound or mammogram ^[9][10].

Next Steps and Management

Because a “cellular fibroepithelial lesion” could potentially be a phyllodes tumor, it is not managed exactly like a routine, clearly diagnosed fibroadenoma ^[9][10]. Management typically involves:

• Multidisciplinary Review: Your care team, which may include surgeons, radiologists, and pathologists, will take a closer look at your case together ^[9][10].
• Expert Pathology Review: Your doctor may request that a breast specialist pathologist review your biopsy slides to look for subtle clues ^[11].
• Correlating with Imaging and Clinical Signs: Your doctor will compare the biopsy with your imaging. A larger or rapidly enlarging mass, particularly in a middle-aged patient, may increase suspicion for a phyllodes tumor ^[9][4]. However, there is no single size or age that rules a phyllodes tumor in or out ^[12][9].

Treatment Options:

• Surgical Excision: To get a definitive answer, doctors most commonly recommend an operation (often called an excisional biopsy or lumpectomy) to remove the entire lump ^[1][9]. This is usually an outpatient procedure, but it does involve anesthesia, scarring, potential changes to breast shape, and risks like bleeding or infection.
• Vacuum-Assisted Excision: In carefully selected cases, a specialized vacuum-assisted needle might be used to remove the entire lesion without open surgery ^[13][10]. However, this method can fragment the tissue, making it harder for the pathologist to assess the edges (margins) of the tumor ^[13].
• Observation: In highly selected cases—such as when the lump is small and imaging looks completely benign—your doctor might discuss close monitoring ^[9][13]. This is not the standard approach and requires a strict follow-up plan to watch for growth or changes.

What Happens After Excision?

Once the whole lump is removed, the pathologist can usually make a final, clear diagnosis ^[5]. Published studies show that when cellular fibroepithelial lesions are surgically removed, the final result is often a fibroadenoma, though many are reclassified as phyllodes tumors ^[1][4][9].

If the final diagnosis is a phyllodes tumor, the pathologist will grade it as benign, borderline, or malignant based on how the cells look ^[14][15]. The final grade and whether the tumor was removed with a clear border of normal tissue (a negative margin) will determine if you need additional surgery or specific follow-up screening to watch for recurrence ^[10].